{"@type": "dcat:Dataset", "accessLevel": "public", "contactPoint": {"@type": "vcard:Contact", "fn": "U.S. Food and Drug Administration (FDA)", "hasEmail": "mailto:no-reply@healthdata.gov"}, "description": "Olanzapine and Fluoxetine is a prescription oral capsule combining an atypical antipsychotic and a serotonin reuptake inhibitor, used to treat certain types of depression. Available in various strengths (e.g., fluoxetine 25mg with olanzapine 3mg), it's manufactured by Endo USA, Inc. under ANDA077742. This information was generated using AI and is provided for informational and research purposes only.", "distribution": [{"@type": "dcat:Distribution", "description": "\n        Access the FDA dataset for Olanzapine and fuoxetine \u2014 ANDA 203308 submitted by Mylan Institutional LLC\n    ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203308", "mediaType": "text/html", "title": "Olanzapine and fuoxetine"}], "identifier": "https://healthdata.gov/api/views/a3bz-yic9", "issued": "2025-11-24", "keyword": ["drug", "drug-manufacturers", "health-care", "pharmaceuticals", "public-health"], "landingPage": "https://healthdata.gov/d/a3bz-yic9", "modified": "2025-11-27", "publisher": {"@type": "org:Organization", "name": "healthdata.gov"}, "theme": ["FDA"], "title": "Olanzapine and fuoxetine"}